Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications

Front Immunol. 2021 Jun 28:12:582556. doi: 10.3389/fimmu.2021.582556. eCollection 2021.

Abstract

Introduction: Several months ago, Chinese authorities identified an atypical pneumonia in Wuhan city, province of Hubei (China) caused by a novel coronavirus (2019-nCoV or SARS-CoV-2). The WHO announced this new disease was to be known as "COVID-19".

Evidence acquisition: Several approaches are currently underway for the treatment of this disease, but a specific cure remains to be established.

Evidence synthesis: This review will describe how the use of selected nutraceuticals could be helpful, in addition to pharmacological therapy, in preventing some COVID-19-related complications in infected patients.

Conclusions: Even if a specific and effective cure for COVID-19 still has some way to go, selected nutraceuticals could be helpful, in addition to pharmacological therapy, in preventing some COVID-19-related complications in infected patients.

Keywords: COVID-19; SARS-CoV-2; infectious diseases; inflammation; nutraceuticals.

Publication types

  • Review

MeSH terms

  • Berberine / therapeutic use
  • COVID-19 / complications*
  • COVID-19 / epidemiology
  • COVID-19 / prevention & control*
  • COVID-19 / virology
  • China / epidemiology
  • Dietary Supplements*
  • Fatty Acids, Omega-3 / therapeutic use
  • Fungal Polysaccharides / therapeutic use
  • Humans
  • Lactoferrin / therapeutic use
  • Minerals / therapeutic use
  • Plant Lectins / therapeutic use
  • Polyphenols / therapeutic use
  • SARS-CoV-2*
  • Soy Foods
  • Vitamins / therapeutic use

Substances

  • Fatty Acids, Omega-3
  • Fungal Polysaccharides
  • Minerals
  • Plant Lectins
  • Polyphenols
  • Vitamins
  • Berberine
  • Lactoferrin